Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol

BACKGROUND: To obtain evidence for the clinical and cost-effectiveness of treatments for patients with rare diseases is a challenge. Non-dystrophic myotonia (NDM) is a group of inherited, rare muscle diseases characterized by muscle stiffness. The reimbursement of mexiletine, the expert opinion drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Stunnenberg, Bas C, Woertman, Willem, Raaphorst, Joost, Statland, Jeffrey M, Griggs, Robert C, Timmermans, Janneke, Saris, Christiaan G, Schouwenberg, Bas J, Groenewoud, Hans M, Stegeman, Dick F, van Engelen, Baziel G M, Drost, Gea, van der Wilt, Gert Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407841/
https://www.ncbi.nlm.nih.gov/pubmed/25880166
http://dx.doi.org/10.1186/s12883-015-0294-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407841/
https://www.ncbi.nlm.nih.gov/pubmed/25880166
http://dx.doi.org/10.1186/s12883-015-0294-4

Ejemplares similares